A 24-Week, Double Blind, Randomized Study to Determine the Effects of 24 Weeks of Dosing With Tripterygium Wilfordii Hook F (TwHF) or Sulfasalazine, in Subjects With Active Rheumatoid Arthritis

Trial Profile

A 24-Week, Double Blind, Randomized Study to Determine the Effects of 24 Weeks of Dosing With Tripterygium Wilfordii Hook F (TwHF) or Sulfasalazine, in Subjects With Active Rheumatoid Arthritis

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Aug 2009

At a glance

  • Drugs Sulfasalazine; Tripterygium wilfordii Hook F
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Aug 2009 Results will be published in the Annals of Internal Medicine, according to a Phytomedics media release.
    • 18 Aug 2009 Results were published in the Annals of Internal Medicine.
    • 05 Jan 2007 Information added from 1057045.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top